Moderna (MRNA) Announces Additional Supply for Q2 2022 of Vaccine for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries
Go back to Moderna (MRNA) Announces Additional Supply for Q2 2022 of Vaccine for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 69.70 +2.43 (3.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.27 | 52 Week High | $0.52 | |||
| Open | $67.94 | 52 Week Low | $0.08 | |||
| Day High | $69.90 | P/E | N/A | |||
| Day Low | $66.30 | EPS | $-3.80 | |||
| Volume | 7,917,807 | |||||
